Literature DB >> 30989192

Resolvin E1 for reducing vascular calcification.

Neil MacRitchie1, Pasquale Maffia1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30989192      PMCID： PMC6648334          DOI： 10.1093/cvr/cvz101

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  15 in total

1.  Specialized pro-resolving mediators: do they circulate in plasma?

Authors:  Robert C Murphy
Journal:  J Lipid Res       Date:  2015-07-31       Impact factor: 5.922

2.  Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses.

Authors:  Sueleyman Bilal; Oliver Haworth; Lijun Wu; Karsten H Weylandt; Bruce D Levy; Jing X Kang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

Review 3.  Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism.

Authors:  Benjamin Bondue; Valérie Wittamer; Marc Parmentier
Journal:  Cytokine Growth Factor Rev       Date:  2011-11-25       Impact factor: 7.638

4.  Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.

Authors:  Karen J Ho; Matthew Spite; Christopher D Owens; Hope Lancero; Alex H K Kroemer; Reena Pande; Mark A Creager; Charles N Serhan; Michael S Conte
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

5.  Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.

Authors:  Hatice Hasturk; Rima Abdallah; Alpdogan Kantarci; Daniel Nguyen; Nicholas Giordano; James Hamilton; Thomas E Van Dyke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-19       Impact factor: 8.311

6.  Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

Authors:  Makoto Arita; Taisuke Ohira; Yee-Ping Sun; Siva Elangovan; Nan Chiang; Charles N Serhan
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

Review 7.  Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.

Authors:  Kazuki Moro; Masayuki Nagahashi; Rajesh Ramanathan; Kazuaki Takabe; Toshifumi Wakai
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

Review 8.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

9.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

10.  BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.

Authors:  Xianwu Li; Hsueh-Ying Yang; Cecilia M Giachelli
Journal:  Atherosclerosis       Date:  2008-01-07       Impact factor: 5.162
View more
  1 in total

Review 1.  Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction.

Authors:  Yingying Xie; Ling Liu
Journal:  J Transl Med       Date:  2022-03-22       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.